{"id":50296,"date":"2022-10-31T21:00:59","date_gmt":"2022-10-31T20:00:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/"},"modified":"2022-10-31T21:00:59","modified_gmt":"2022-10-31T20:00:59","slug":"crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/","title":{"rendered":"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–#CRISPR<\/a>–On October 26th <\/sup>2022, CRISPR QC has announced that Toby Richardson, PhD has been appointed to the board of directors.\n<\/p>\n

<\/a><\/p>\n

\nCRISPR QC has already started proving that the unique capabilities of our CRISPR Analytics Platform can interrogate previously unknowable dimensions of gene editing that is translating into real value for our customers,\u201d says Ross Bundy, CEO. \u201cThe next step in our development is taking this unique insight and building greater depth to our data and analytics capabilities. Dr. Richardson\u2019s extensive experience in this space will be key to guiding this emerging aspect of our business.\u201d\n<\/p>\n

\n“I am honored to join CRISPR QC\u2019s board. CRISPR QC\u2019s CRISPR analytics platform is one of a kind, with many new types of data-driven insights that therapeutics, biotech, and agtech companies will greatly benefit from. I look forward to contributing to CRISPR QC\u2019s data strategy to realize its full potential,” says Toby Richardson, PhD.\n<\/p>\n

\nDr. Richardson co-founded Denovium inc in 2018, a company that used state of the art deep learning technology to solve the big data issues facing the pharmaceutical and industrial biotech sectors. Toby brings over two decades of industrial experience leading bioinformatics teams and developing and commercializing genomics software. Toby has served on the board of Agracast and is a scientific advisor to several Biotech companies. He is the author of more than 30 peer reviewed publications and is an inventor on more than 20 patents. Dr. Richardson received his PhD in Drug Metabolism from the University of Surrey.\n<\/p>\n

\nCRISPR has the potential to be the defining technology of the 21st<\/sup> century. CRISPR is showing promise to cure previously uncurable diseases, secure our food supply, and much more. However, these advancements are not without risks or blind spots. The need for quality control and insight has grown concurrently with the advances and successes of CRISPR gene editing. At CRISPR QC we utilize our CRISPR Analytics Platform, powered by the CRISPR-Chip\u2122, to optimize and de-risk gene editing outcomes by providing a new form of insight into CRISPR.\n<\/p>\n

\nAbout CRISPR QC<\/b>\n<\/p>\n

\nAt CRISPR QC, we\u2019re working to empower the scientists, researchers, and doctors at the front lines of the genetic engineering revolution. Our CRISPR Analytics Platform provides the data and insights they need to power the safest, most efficacious gene editing outcomes.\n<\/p>\n

\nTo learn more about CRISPR QC, visit www.crisprqc.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nRoss Bundy, President
\n
CRISPR QC
\n
858-444-0037
\n
rbundy@crisprqc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–#CRISPR–On October 26th 2022, CRISPR QC has announced that Toby Richardson, PhD has been appointed to the board of directors. CRISPR QC has already started proving that the unique capabilities of our CRISPR Analytics Platform can interrogate previously unknowable dimensions of gene editing that is translating into real value for our customers,\u201d says … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50296","6":"format-standard","7":"category-industry"},"yoast_head":"\nCRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–#CRISPR–On October 26th 2022, CRISPR QC has announced that Toby Richardson, PhD has been appointed to the board of directors. CRISPR QC has already started proving that the unique capabilities of our CRISPR Analytics Platform can interrogate previously unknowable dimensions of gene editing that is translating into real value for our customers,\u201d says ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-31T20:00:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221031005191\/en\/1425692\/21\/CRISPR_QC_Logo_RGB-02.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors\",\"datePublished\":\"2022-10-31T20:00:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/\"},\"wordCount\":417,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005191\\\/en\\\/1425692\\\/21\\\/CRISPR_QC_Logo_RGB-02.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/\",\"name\":\"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005191\\\/en\\\/1425692\\\/21\\\/CRISPR_QC_Logo_RGB-02.jpg\",\"datePublished\":\"2022-10-31T20:00:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005191\\\/en\\\/1425692\\\/21\\\/CRISPR_QC_Logo_RGB-02.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221031005191\\\/en\\\/1425692\\\/21\\\/CRISPR_QC_Logo_RGB-02.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–#CRISPR–On October 26th 2022, CRISPR QC has announced that Toby Richardson, PhD has been appointed to the board of directors. CRISPR QC has already started proving that the unique capabilities of our CRISPR Analytics Platform can interrogate previously unknowable dimensions of gene editing that is translating into real value for our customers,\u201d says ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-31T20:00:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221031005191\/en\/1425692\/21\/CRISPR_QC_Logo_RGB-02.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors","datePublished":"2022-10-31T20:00:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/"},"wordCount":417,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005191\/en\/1425692\/21\/CRISPR_QC_Logo_RGB-02.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/","url":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/","name":"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221031005191\/en\/1425692\/21\/CRISPR_QC_Logo_RGB-02.jpg","datePublished":"2022-10-31T20:00:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221031005191\/en\/1425692\/21\/CRISPR_QC_Logo_RGB-02.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221031005191\/en\/1425692\/21\/CRISPR_QC_Logo_RGB-02.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/crispr-qc-appoints-dr-toby-richardson-to-crispr-qc-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CRISPR QC Appoints Dr. Toby Richardson to CRISPR QC Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50296","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50296"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50296\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50296"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50296"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50296"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}